Enzymatic Modifications of Protein S: Implications for Diagnostics and Anticoagulant Function
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Enzymatic modifications of protein S: cause and impact on diagnostics, plasma processing, and anticoagulant properties
This review discusses how enzymatic modifications, such as phosphorylation and proteolysis, can alter the anticoagulant functions of protein S, which is essential for downregulating coagulation.
These changes can impact diagnostic procedures, plasma product quality, and overall thrombosis risk, highlighting new opportunities for improved therapies and clinical diagnostics.
Read this paper.
Authors: Herm Jan Brinkman”
Article: Enzymatic modifications of protein S: cause and impact on diagnostics, plasma processing, and anticoagulant properties
Authors: Herm Jan Brinkman
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026
-
Jul 13, 2026, 09:46Fabrice Cognasse: Is There Such a Thing as the Perfect Platelet Product?
-
Jul 13, 2026, 09:42Cancer-Associated Arterial Thromboembolism: Redefining the Thrombotic Burden in Oncology
-
Jul 13, 2026, 05:59Connecting and Collaborating at ISTH 2026 – NNHF
-
Jul 13, 2026, 05:58Lara Monica: Back at ISTH – Looking Forward to Science and Reconnections!
-
Jul 13, 2026, 05:57Barbara Adams Krolak: Exciting Updates From the ISTH 2026 Regulatory Session